Home›People›Andre Basbaum
Andre Basbaum

Andre Basbaum

President & CEO, director at Resolute Science.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Apr 3, 2026·Suggest an edit

About Andre Basbaum

Andre Basbaum is a president & CEO, director at Resolute Science.

Andre Basbaum first appears on SEC filings in 2024.

Experience

This experience comes from Andre Basbaum's profile and from SEC filings. For roles taken from filings, the years are when the filings name Andre Basbaum in the role, so the role may have started earlier or lasted longer.

Resolute Science, Inc. Current
President & CEO, Board of Directors
2023 – Present · San Diego, CA
Develops cancer treatments for people with solid tumors.
Siolta Therapeutics Current
Business Advisory Board
2022 – Present
Infinity Stone Ventures Corporation
Consultant, Strategic Advisor
2020 – 2021
ACEA Therapeutics, Inc
Vice President, Business Development
2016 – 2019
Trovagene, Inc.
Senior Director, Business Development
2015 – 2016
SGB Inc.
Head, Corporate Development
2012 – 2014
VentiRx Pharmaceuticals, Inc.
Director, Business Development
2006 – 2011
Valeant Pharmaceuticals
Senior Manager, Business Development
2004 – 2006
Anadys Pharmaceuticals, Inc.
Senior Manager, Corporate Development
2001 – 2004
Pfizer Inc.
Global Market Planning
2000 – 2001

Key Colleagues at Startups

The people Andre Basbaum works with at each company, as listed on that company's latest Form D.

Resolute Science, Inc. · Form D/A, Apr 3, 2026
James Mackay
James Mackay
Independent Chairman
Faith Barnett
Faith Barnett
Founder & CSO, director

Sources

  1. SECResolute Science, Inc. Form D/A, filed Apr 3, 2026